Genentech

Genentech is one of the founding companies of the modern biotechnology industry and has played a transformative role in advancing medical science since its establishment in 1976. Headquartered in South San Francisco, California, the company is a member of the Roche Group and focuses on discovering, developing, and manufacturing innovative medicines for patients with serious and life-threatening diseases. Genentech is particularly recognized for breakthroughs in oncology, immunology, neuroscience, ophthalmology, and rare diseases.

Over the decades, the company has introduced numerous first-in-class therapies and has become a global leader in precision medicine and targeted biologics. Its research strategy integrates molecular biology, genetics, artificial intelligence, and advanced data science to accelerate drug discovery and improve patient outcomes. Genentech operates world-class research campuses and manufacturing facilities in the United States while collaborating with academic institutions, healthcare organizations, and biotechnology partners worldwide.

The company places significant emphasis on scientific innovation, responsible business practices, diversity, and patient-centered healthcare solutions. Through continuous investment in research and clinical development, Genentech maintains one of the strongest biotechnology pipelines in the industry. Its commitment to pioneering science has earned worldwide recognition and continues to influence the future of personalized medicine, making Genentech one of the most respected biotechnology companies globally.